In September 2023, the FDA classified BPC-157 as a Category 2 compound under the 503A bulking list, restricting its use by American compounding pharmacies
31 Tips for safer colchicine use: 8, 26, 28 Prescribe the lowest effective dose and provide clear instructions on how and when to take it Advise patients to stop taking colchicine and seek medical attention if they experience nausea, vomiting, diarrhoea or abdominal pain Limit prescriptions to the anticipated number of tablets required for managing an acute attack of gout
Musculoskeletal Research In muscle injury models, BPC-157 has shown remarkable efficacy in promoting recovery from muscle crush injuries, lacerations, and contusions, with studies documenting reduced inflammation, faster tissue regeneration, and improved functional recovery
A batch-specific Certificate of Analysis (CoA) accompanies every order, confirming identity, purity, and HPLC verification results